Bulletin
Investor Alert

ACADIA Pharmaceuticals Inc.

NAS: ACAD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205236646/composite

$

20.72

Change

-0.46 -2.17%

Volume

Volume 198,408

Jan 21, 2022, 6:14 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205236646/composite

Previous close

$ 21.49

$ 21.18

Change

-0.31 -1.44%

Day low

Day high

$20.94

$22.05

Open
Open: 21.39

52 week low

52 week high

$15.68

$54.58

Open

Market cap

$3.45B

Average volume

1.76M

P/E ratio

N/A

Rev. per Employee

$789,341

EPS

-1.20

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/acad

MarketWatch News on ACAD

  1. 5 Biotech Stocks That Could Lead a Revival

    1:05 p.m. Sept. 6, 2021

    - Barron's Online

  2. 5 Undervalued Healthcare Stocks

    10:54 a.m. June 16, 2021

    - Barron's Online

  3. Will Biotech Stocks' Slide Become a Rout? June Holds the Key.

    1:46 p.m. May 14, 2021

    - Barron's Online

  4. Acadia Pharmaceuticals stock price target cut to $26 from $40 at Canaccord Genuity

    8:10 a.m. April 6, 2021

    - Tomi Kilgore

  5. Acadia Pharmaceuticals downgraded to hold at Canaccord Genuity

    8:10 a.m. April 6, 2021

    - Tomi Kilgore

  6. Acadia Is Hit by Wave of Downgrades After FDA Rejection

    7:31 a.m. April 6, 2021

    - Barron's Online

  7. Acadia Pharmaceuticals stock price target cut to $25 from $37 at Mizuho

    5:42 a.m. April 6, 2021

    - Tomi Kilgore

  8. Acadia Pharmaceuticals downgraded to neutral from buy at Mizuho

    5:42 a.m. April 6, 2021

    - Tomi Kilgore

  9. The FDA Is Clamping Down. What to Know.

    6:16 a.m. March 29, 2021

    - Barron's Online

  10. Acadia Pharmaceuticals stock price target cut to $37 from $55 at Mizuho

    6:50 a.m. March 12, 2021

    - Tomi Kilgore

  11. Acadia Pharmaceuticals stock price target cut to $40 from $61 at Canaccord Genuity

    9:23 a.m. March 9, 2021

    - Tomi Kilgore

  12. Acadia Shares Plummet After FDA Finds Flaws in Drug Application

    8:18 a.m. March 9, 2021

    - Barron's Online

  13. Acadia Pharmaceuticals downgraded to outperform from strong buy at Raymond James

    7:45 a.m. March 9, 2021

    - Tomi Kilgore

  14. Acadia Pharmaceuticals stock price target cut to $42 from $60 at J.P. Morgan

    7:42 a.m. March 9, 2021

    - Tomi Kilgore

  15. Acadia Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus

    6:59 a.m. March 9, 2021

    - Tomi Kilgore

  16. Acadia Pharmaceuticals stock price target cut to $27 from $68 at Stifel Nicolaus

    6:59 a.m. March 9, 2021

    - Tomi Kilgore

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/acad

Other News on ACAD

  1. Tracking Baker Brothers Portfolio - Q3 2021 Update

    10:32 p.m. Jan. 4, 2022

    - Seeking Alpha

  2. JAGX, SEAC and EQOS among mid-day movers

    12:26 p.m. Dec. 21, 2021

    - Seeking Alpha

  3. Acadia Pharmaceuticals promotes Mark Schneyer to EVP CFO

    9:23 a.m. Dec. 14, 2021

    - Seeking Alpha

  4. Loading more headlines...
/news/pressrelease/company/us/acad

Press Releases on ACAD

  1. Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results

    4:05 p.m. Nov. 8, 2021

    - BusinessWire - BZX

  2. Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

    8:00 a.m. Sept. 2, 2021

    - BusinessWire - BZX

  3. Acadia Pharmaceuticals Announces Executive Leadership Change

    3:05 p.m. Sept. 1, 2021

    - BusinessWire - BZX

  4. Parkinson Disease Therapeutics Market Outlook 2021-2027 By Industry Players

    10:28 p.m. Aug. 25, 2021

    - Market Insight Reports

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.